Debashish Bose

1.0k total citations
17 papers, 743 citations indexed

About

Debashish Bose is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Debashish Bose has authored 17 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Debashish Bose's work include Pancreatic and Hepatic Oncology Research (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Renal cell carcinoma treatment (2 papers). Debashish Bose is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Renal cell carcinoma treatment (2 papers). Debashish Bose collaborates with scholars based in United States, Switzerland and Netherlands. Debashish Bose's co-authors include Lee M. Ellis, Puja Gaur, Nikolaos A. Dallas, Shaija Samuel, J. Hartwell Harrison, Peter A. Humphrey, Ling Xia, John A. Maksem, Robert H. Young and John R. Srigley and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

In The Last Decade

Debashish Bose

17 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debashish Bose United States 13 336 273 269 141 112 17 743
Julie Steinestel Germany 19 351 1.0× 304 1.1× 473 1.8× 306 2.2× 69 0.6× 42 1.0k
Enrica Vitarelli Italy 17 269 0.8× 213 0.8× 159 0.6× 114 0.8× 47 0.4× 52 797
Martin Faehling Germany 14 190 0.6× 342 1.3× 459 1.7× 86 0.6× 38 0.3× 45 792
Parula Mehta United States 9 234 0.7× 315 1.2× 172 0.6× 116 0.8× 109 1.0× 11 654
Shun‐Dong Dai China 21 640 1.9× 235 0.9× 184 0.7× 143 1.0× 50 0.4× 47 917
Amy S. Woodard United States 7 637 1.9× 193 0.7× 237 0.9× 122 0.9× 54 0.5× 8 1.1k
Osamu Nagakawa Japan 14 182 0.5× 199 0.7× 178 0.7× 122 0.9× 22 0.2× 34 570
Kelly J. Gordon United States 7 701 2.1× 315 1.2× 121 0.4× 156 1.1× 78 0.7× 10 1.0k
Rongkui Luo China 14 187 0.6× 169 0.6× 227 0.8× 77 0.5× 35 0.3× 83 713
Heng‐hui Ma China 19 668 2.0× 213 0.8× 457 1.7× 320 2.3× 36 0.3× 65 1.0k

Countries citing papers authored by Debashish Bose

Since Specialization
Citations

This map shows the geographic impact of Debashish Bose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debashish Bose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debashish Bose more than expected).

Fields of papers citing papers by Debashish Bose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debashish Bose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debashish Bose. The network helps show where Debashish Bose may publish in the future.

Co-authorship network of co-authors of Debashish Bose

This figure shows the co-authorship network connecting the top 25 collaborators of Debashish Bose. A scholar is included among the top collaborators of Debashish Bose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debashish Bose. Debashish Bose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Huang, Grace C., et al.. (2022). Molecular Characteristics and Immunogenomic Profiling of Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma in a 68-year-old Patient. Anticancer Research. 42(11). 5475–5478. 5 indexed citations
2.
Ris, Frédéric, Minia Hellan, Jonathan Douissard, et al.. (2021). Blood-Based Multi-Cancer Detection Using a Novel Variant Calling Assay (DEEPGENTM): Early Clinical Results. Cancers. 13(16). 4104–4104. 12 indexed citations
3.
Hitchcock, Kathryn, R.C. Nichols, Christopher G. Morris, et al.. (2017). Feasibility of pancreatectomy following high-dose proton therapy for unresectable pancreatic cancer. World Journal of Gastrointestinal Surgery. 9(4). 103–103. 12 indexed citations
4.
Royall, Nelson A. & Debashish Bose. (2015). Impact of neoadjuvant therapy on the surgical management of pancreatic cancer: a literature review. Translational Cancer Research. 4(6). 641–652. 2 indexed citations
5.
Sachsman, Suzanne M., R.C. Nichols, Christopher G. Morris, et al.. (2014). Proton Therapy and Concomitant Capecitabine for Non-Metastatic Unresectable Pancreatic Adenocarcinoma. International Journal of Particle Therapy. 1(3). 692–701. 37 indexed citations
6.
Sankpal, Umesh T., Pius Maliakal, Debashish Bose, et al.. (2012). Expression of Specificity Protein Transcription Factors in Pancreatic Cancer and their Association in Prognosis and Therapy. Current Medicinal Chemistry. 19(22). 3779–3786. 38 indexed citations
7.
Samuel, Shaija, Puja Gaur, Fan Fan, et al.. (2011). Neuropilin-2 Mediated β-Catenin Signaling and Survival in Human Gastro-Intestinal Cancer Cell Lines. PLoS ONE. 6(10). e23208–e23208. 31 indexed citations
8.
Bose, Debashish, Lisa J. Zimmerman, Mariaelena Pierobon, et al.. (2011). Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells. British Journal of Cancer. 105(11). 1759–1767. 69 indexed citations
9.
Fan, Fei, Samson Mathews Samuel, Puja Gaur, et al.. (2011). Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration. British Journal of Cancer. 104(8). 1270–1277. 82 indexed citations
10.
Tozzi, Federico, Yan Zhou, Jiefu Chen, et al.. (2011). Evaluation of glycolytic activity and HIF-1α expression in chemoresistant colorectal cancer cells.. Journal of Clinical Oncology. 29(4_suppl). 415–415. 3 indexed citations
11.
Bose, Debashish, Eric P. Tamm, Jun Liu, et al.. (2010). Multidisciplinary Management Strategy for Incidental Cystic Lesions of the Pancreas. Journal of the American College of Surgeons. 211(2). 205–215. 20 indexed citations
12.
Bose, Debashish, Funda Meric‐Bernstam, Wayne L. Hofstetter, et al.. (2010). Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care. The Lancet Oncology. 11(4). 373–382. 94 indexed citations
13.
Gaur, Puja, Debashish Bose, Shaija Samuel, & Lee M. Ellis. (2009). Targeting Tumor Angiogenesis. Seminars in Oncology. 36(2 Suppl 1). S12–S19. 29 indexed citations
14.
Gaur, Puja, Diane R. Bielenberg, Shaija Samuel, et al.. (2009). Role of Class 3 Semaphorins and Their Receptors in Tumor Growth and Angiogenesis. Clinical Cancer Research. 15(22). 6763–6770. 115 indexed citations
15.
Badgwell, Brian D., Janice N. Cormier, Yan Xing, et al.. (2008). Attempted Salvage Resection for Recurrent Gastric or Gastroesophageal Cancer. Annals of Surgical Oncology. 16(1). 42–50. 9 indexed citations
16.
Hunter, John C., Cynthia C. Smith, Debashish Bose, et al.. (1995). Intracellular Internalization and Signaling Pathways Triggered by the Large Subunit of HSV-2 Ribonucleotide Reductase (ICP10). Virology. 210(2). 345–360. 22 indexed citations
17.
Bostwick, David G., John R. Srigley, David Grignon, et al.. (1993). Atypical adenomatous hyperplasia of the prostate: Morphologic criteria for its distinction from well-differentiated carcinoma. Human Pathology. 24(8). 819–832. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Steinestel Breakdown of academic impact, for papers by Enrica Vitarelli Breakdown of academic impact, for papers by Martin Faehling Breakdown of academic impact, for papers by Parula Mehta Breakdown of academic impact, for papers by Shun‐Dong Dai Breakdown of academic impact, for papers by Amy S. Woodard Breakdown of academic impact, for papers by Osamu Nagakawa Breakdown of academic impact, for papers by Kelly J. Gordon Breakdown of academic impact, for papers by Rongkui Luo Breakdown of academic impact, for papers by Heng‐hui Ma
Rankless by CCL
2026